BioRestorative Therapies Receives A Second Patent in Australia For Its Metabolic Program
23 oct. 2019 09h45 HE
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., Oct. 23, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that the...
BioRestorative Therapies Announces New Initiative to Target Polycystic Ovarian Syndrome
11 sept. 2019 08h00 HE
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., Sept. 11, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that it...
BioRestorative Therapies’ Stockholders Approve Institutional Investor Agreement and Exchange Agreements
05 sept. 2019 09h45 HE
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., Sept. 05, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that, at...
BioRestorative Therapies Signs $5.4 Million Financing with Institutional Investor
31 juil. 2019 09h45 HE
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., July 31, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that it...
American CryoStem Selected as "Incubator Company of the Year" by New Jersey Business Incubation Network (NJBIN)
09 avr. 2014 09h06 HE
|
American CryoStem Corp.
EATONTOWN, N.J., April 9, 2014 (GLOBE NEWSWIRE) -- American CryoStem Corporation (OTCQB:CRYO), a leading biotechnology developer and global licensor of patented adipose tissue-based adult stem cell...